Short term clinical outcomes for intravitreal dexamethasone implant in retinal vein occlusion patients [Retina ven tikanikligi olgularinda vitre içi deksametazon implantinin kisa dönem sonuçlar]

Purpose: To evaluate short term results of intravitreal dexamethasone implant for macular edema due to retinal branch vein occlusion (BRVO) and central vein occlusion(CRVO). Material and Methods: 31 eyes of 31 patients (15 male,16 female, mean age:59.7) with either BRVO or CRVO were assessed during 6 months prospectively .Treatment naive patients who had 0.05) at 3rd and 6th month visits, respectively in CRVO subjects. CMT (μm) decreased with mean difference of 177.75 μm (p0.05) at 3rd and 6th month visits, respectively in CRVO subjects. BCVA (logMAR) improved with mean difference score of 0.17 (p0.05) at 3rd and 6th month visits, respectively in BRVO subjects. 3 of 31 eyes which had high IOP (≥21 mmHg) were controlled with medical treatment. 8 of 31 cases had mild cataract and none need cataract surgery. Conclusions: Intravitreal dexamethasone implant can be considered as long term effective choice for CME with BRVO and CRVO compared to intravitreal anti-VEGF treatment. Moreover, it is a safer treatment alternative than triamcinolone for side effect of steroids. © 2016 Gazi Eye Foundation. All Rights Reserved